Outset Medical (OM) Depreciation & Amortization (CF) (2019 - 2026)

Outset Medical (OM) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $795000.0 in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 38.56% year-over-year to $795000.0 in Q1 2026; TTM through Mar 2026 was $3.8 million, a 30.92% decrease from a year earlier, with the FY2025 full-year figure at $4.3 million, down 24.21% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $795000.0, down from $881000.0 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for OM reached as high as $1.5 million in Q2 2023 and fell as low as $795000.0 in Q1 2026.
• Historically, Depreciation & Amortization (CF) has averaged $1.3 million across 5 years, with a median of $1.3 million in 2022.
• Across the five-year window, Depreciation & Amortization (CF) advanced 14.35% in 2023 and slumped 38.56% in 2026, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $1.3 million in 2022, then climbed by 13.95% to $1.4 million in 2023, then declined by 2.77% to $1.4 million in 2024, then sank by 37.34% to $881000.0 in 2025, then slipped by 9.76% to $795000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $795000.0 in Q1 2026, $881000.0 in Q4 2025, and $1.0 million in Q3 2025.